Below is a report from IP Organisers (an independent service company of Phillips Ormonde Fitzpatrick) detailing Australian Pharmaceutical Patents (that have been granted extensions) and that are due to expire in the coming month.
This report covers Australian patents whose Extension of Term expires in March 2014.Â
 ![ip org](http://www.pof.com.au/wp-content/uploads/2013/10/ip-org.jpg)
Â
Australian Pharmaceutical Patents
Expiring March 2014
Â
www.iporganisers.com/pharma/march2014.htm
|
Â
Â
Active Ingredient
|
Tirofiban hydrochloride
|
Trade Name
|
Affrastat
|
Chemical Name
|
N-(butylsulfonyl)-O-[4-(4-piperidinyl)butyl]-L-tyrosine monohydrochloride monohydrate
|
Chemical Structure
|
Â
Â
|
Australian Patent
|
AU-B-655436
|
Expiry Date
|
16 March 2014
|
Patent Assignee
|
Correvio LLC
|
Title
|
Novel sulfonamide fibrinogen receptor antagonists
|
Abstract
|
A series of non-peptide derivatives of generic formula I that are antagonists of the fibrinogen IIb/IIIa receptor and thus are platelet anti-aggregation compounds useful in the prevention and treatment of diseases caused by thrombus formation.
|
Australian Register of Therapeutic Goods
|
ARTG ID 65161
ARTG ID 65162
|
Consumer Medicine Information
|
Aggrastat (Tirofiban hydrochloride)
|
Product Information
|
Aggrastat (Tirofiban hydrochloride)
|
For further information please contact Rodney Chiang-Cruise or Aaron McMillan at IP Organisers Pty Ltd
|
Â